Welcome to the 8th Microbiome Movement - Drug Development Summit

With milestone drug approvals energizing the microbiome drug development space, it is both an exciting and critical time to be working in the field. Drug developers have gotten more sophisticated in understanding the role of the microbiome in disease. It is clear how to harness functionally relevant microbes for live biotherapeutic approaches and there is an increased quality of drug candidates progressing through the clinic

That’s why members from the entire drug development spectrum, from discovery, preclinical, translational, manufacturing, clinical and regulatory through to commercialization, are gathering at the 8th Microbiome Movement – Drug Development Summit.

Join pioneering drug developers and technology enablers to share cutting-edge science, preclinical and clinical trial data, to move the needle forward on microbial-based drug development innovation and healthcare industry adoption.

As commercialization of novel drug candidates becomes an increasing priority, join the premier forum in the microbiome drug development space to demonstrate efficacy horsepower of LBPs across a diversity of diseases, secure funding for continued R&D, and launch ground-breaking therapies into market.

• Dive into interactive sessions, from discussion-based workshops, roundtables, panel discussions, Q&As & speed networking- make new connections to accelerate future collaboration.
• Delve deeper into critical areas of research that are propelling the industry forward through our double streamed pre-conference day. Exploring bioconvergence and analytical technologies, biomarker discovery, advancements in translation, regulatory & postbiotics!
• Explore your personal topics of interest through our three tracks Discovery, Pre-clincal &Translation and Clinical & Manufacturing
• Discover new content for 2023 from leveraging the fungal and viral components of the microbiome, tuning the microbiome using bacterial engineering, exploring medical foods, securing capital to scale your biotech business